PT94214A - Processo para a preparacao de composicoes farmaceuticas uteis para a inducao de tolerancia que contem anticorpos monoclonais - Google Patents

Processo para a preparacao de composicoes farmaceuticas uteis para a inducao de tolerancia que contem anticorpos monoclonais

Info

Publication number
PT94214A
PT94214A PT94214A PT9421490A PT94214A PT 94214 A PT94214 A PT 94214A PT 94214 A PT94214 A PT 94214A PT 9421490 A PT9421490 A PT 9421490A PT 94214 A PT94214 A PT 94214A
Authority
PT
Portugal
Prior art keywords
utical
preparation
pharmaceutical compositions
monoclonal antibodies
tolerance induction
Prior art date
Application number
PT94214A
Other languages
English (en)
Other versions
PT94214B (pt
Inventor
Herman Waldmann
Original Assignee
Cobbold Stephen P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobbold Stephen P filed Critical Cobbold Stephen P
Publication of PT94214A publication Critical patent/PT94214A/pt
Publication of PT94214B publication Critical patent/PT94214B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PT94214A 1989-05-31 1990-05-31 Processo para a preparacao de composicoes farmaceuticas que contem anticorpos monoclonais PT94214B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898912497A GB8912497D0 (en) 1989-05-31 1989-05-31 Monoclonal antibodies

Publications (2)

Publication Number Publication Date
PT94214A true PT94214A (pt) 1991-02-08
PT94214B PT94214B (pt) 1997-03-31

Family

ID=10657649

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94214A PT94214B (pt) 1989-05-31 1990-05-31 Processo para a preparacao de composicoes farmaceuticas que contem anticorpos monoclonais

Country Status (19)

Country Link
EP (1) EP0474691B1 (pt)
JP (1) JP2763197B2 (pt)
KR (1) KR0183029B1 (pt)
AT (1) ATE145246T1 (pt)
AU (1) AU657255B2 (pt)
CA (1) CA2055615C (pt)
DD (1) DD296843A5 (pt)
DE (1) DE69029134T2 (pt)
DK (1) DK0474691T3 (pt)
ES (1) ES2096588T3 (pt)
GB (1) GB8912497D0 (pt)
HU (1) HUT61341A (pt)
IE (1) IE80735B1 (pt)
IL (1) IL94566A0 (pt)
MY (1) MY135673A (pt)
NZ (1) NZ233889A (pt)
PT (1) PT94214B (pt)
WO (1) WO1990015152A1 (pt)
ZA (1) ZA904174B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100741D0 (en) * 1991-01-14 1991-02-27 Univ London Treatment of disease
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
WO1994004188A1 (en) * 1992-08-21 1994-03-03 Genentech, Inc. Method for treating an lfa-1-mediated disorder
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
DE69627665T2 (de) * 1995-05-18 2004-02-19 Ortho-Mcneil Pharmaceutical, Inc. Induktion von immunologischer toleranz unter verwendung von nicht-zellmengeverringernden anti-cd4-antikoepern
EP1212422B1 (en) 1999-08-24 2007-02-21 Medarex, Inc. Human ctla-4 antibodies and their uses
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
ES2316446T3 (es) 2000-04-29 2009-04-16 University Of Iowa Research Foundation Diagnostico y terapeutica para trastornos relacionados con la degeneracion macular.
CA2450700A1 (en) * 2001-06-14 2002-12-27 Mark Frewin Trx1 antibody and uses therefor
US7541443B2 (en) 2001-06-14 2009-06-02 Tolerrx, Inc. Anti-CD4 antibodies
EP1460088A1 (en) 2003-03-21 2004-09-22 Biotest AG Humanized anti-CD4 antibody with immunosuppressive properties
GB0314461D0 (en) * 2003-06-20 2003-07-23 Isis Innovation Suppression of transplant rejection
KR20070036138A (ko) * 2004-06-22 2007-04-02 톨러알엑스, 인크. 영장류에서 관용 유발을 위한 항-ｃｄ４ 항체를 사용하는최적화 용량 결정
WO2009121690A1 (en) 2008-03-13 2009-10-08 Biotest Ag Agent for treating disease
RU2540018C2 (ru) 2008-03-13 2015-01-27 Биотест Аг Средство для лечения заболевания
CN102027016A (zh) 2008-03-13 2011-04-20 生物测试股份公司 一种治疗疾病的试剂
EP2297204A4 (en) * 2008-06-06 2013-10-23 Baylor Res Inst ANTI-CD8 ANTIBODIES BLOCK THE PRIMES OF CYTOTOXIC EFFECTORS AND LEAD TO THE FORMATION OF REGULATORY CD8 + T CELLS
US20100021460A1 (en) * 2008-07-15 2010-01-28 Genentech, Inc. Methods of Treating Autoimmune Diseases Using CD4 Antibodies
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies

Also Published As

Publication number Publication date
JPH04505919A (ja) 1992-10-15
JP2763197B2 (ja) 1998-06-11
DE69029134D1 (de) 1996-12-19
PT94214B (pt) 1997-03-31
DK0474691T3 (da) 1996-12-02
AU5725890A (en) 1991-01-07
IE901949L (en) 1990-11-30
DD296843A5 (de) 1991-12-19
MY135673A (en) 2008-06-30
NZ233889A (en) 1997-06-24
EP0474691A1 (en) 1992-03-18
ATE145246T1 (de) 1996-11-15
CA2055615A1 (en) 1990-12-13
IE80735B1 (en) 1998-12-30
EP0474691B1 (en) 1996-11-13
IL94566A0 (en) 1991-03-10
KR0183029B1 (ko) 1999-04-01
AU657255B2 (en) 1995-03-09
HU905134D0 (en) 1992-02-28
HUT61341A (en) 1992-12-28
CA2055615C (en) 2001-07-17
GB8912497D0 (en) 1989-07-19
ES2096588T3 (es) 1997-03-16
ZA904174B (en) 1992-02-26
DE69029134T2 (de) 1997-03-06
WO1990015152A1 (en) 1990-12-13

Similar Documents

Publication Publication Date Title
PT94214A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a inducao de tolerancia que contem anticorpos monoclonais
Palmer et al. Immunization with an isolate-common surface protein protects cattle against anaplasmosis
FR2322373A1 (fr) Methode et necessaire de dosage immunologique d'un antigene en phase solide
IL74156A (en) Method for the preparation of a monoclonal antibody and of an immortalized cell producing the same and pharmaceutical compositions containing the monoclonal antibody
ATE233102T1 (de) Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten
PT84258B (pt) Processo para a preparacao de anticorpos monoclonais humanos de proteccao cruzada e de composicoes farmaceuticas que os contem
BR9709958A (pt) Polipeptídeos capaz de formar estruturas de ligaçãode antígeno com especificidade para os antígenos de rhesus d o dna que os codifica e o processo para sua preparação e uso
MY107079A (en) Method of reducing immunoglobulin e responses
SE8404250D0 (sv) Antigen for tidig graviditetsprovning och kontraceptivt vaccin
EP0335134A3 (en) Mouse monoclonal antibody to human immunodeficiency virus gp41 protein
PT92235A (pt) Processo para a preparacao de um anticorpo monoclonal anti-fucosilceramida e de agentes de diagnostico que o contem
KR870700023A (ko) 녹농균의 E8Ag항원 및 그것에 대한 모노클로날 항체및 하이브리도마
Coe The immune response in the hamster: II. Studies on IgM
DE69014116D1 (de) Immunoassay zur bestimmung der bindungsspezifität eines monoklonalen antikörpers.
Zavaleta et al. Immunological memory to an autoantigen: The in vitro response to thyroglobulin
Montgomery et al. Molecular diversity of secretory IgA anti-DNP antibodies elicited in rat bile.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
DE69025629T2 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DE69322960D1 (de) Empfängnisverhütender impfstoff
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
GB1155683A (en) New Polyvalent Immunizing Agents and Methods for their Production
Rees Macroglobulin changes in sheep infected with Trypanosoma vivax
IT1254570B (it) Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione.
ES451111A2 (es) Metodo de obtencion de antimeros y anticuerpos para diagnos-tico y tratamiento del cancer.
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961223

PC3A Transfer or assignment

Free format text: 971218 WELLCOME FOUNDATION LIMITED, THE GB

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20110624

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20111223